Janssen Vaccines (redirect from Crucell)
4°28′02″E / 52.1655°N 4.4673°E / 52.1655; 4.4673 Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical...
5 KB (434 words) - 00:59, 12 November 2024
Cilag AG Janssen Biotech (formerly Centocor) Janssen Vaccines (formerly Crucell) Tibotec The early roots of what would become Janssen Pharmaceuticals date...
33 KB (3,169 words) - 09:16, 2 November 2024
GAVI-supported countries to introduce the five-in-one vaccine. In May 2010, Crucell N.V. announced a US$110 million award from UNICEF to supply its pentavalent...
21 KB (1,759 words) - 01:25, 14 November 2024
of antigen adsorbed on aluminium hydroxide (0.3 mg Al). Epaxal: made by Crucell. Also sold under the brand names HAVpur and VIROHEP-A. This vaccine consists...
18 KB (1,612 words) - 02:59, 12 November 2024
continued through 2002.: 221 The United States and the Dutch company Crucell collaborated to begin development on an ebola vaccine in response.: 222 ...
129 KB (12,699 words) - 00:12, 17 November 2024
prevention of typhoid: the live, oral Ty21a vaccine (sold as Vivotif by Crucell Switzerland AG) and the injectable typhoid polysaccharide vaccine (sold...
96 KB (10,675 words) - 03:23, 26 October 2024
Solutions and the Human Performance Institute. In October 2010, J&J acquired Crucell for $2.4 billion. The subsidiary operates as the centre for vaccines, within...
116 KB (11,245 words) - 20:29, 7 November 2024
government had been interested in letting Crucell work together with the Netherlands Vaccine Institute [nl], with Crucell offering the Netherlands a rapid vaccine...
14 KB (1,256 words) - 03:28, 29 June 2024
improve health for expectant mothers and their children. In May 2010, Crucell N.V. announced an additional US$110 million award from UNICEF to supply...
64 KB (6,852 words) - 01:39, 9 November 2024
research spin-offs. Prominent examples of university spin-offs are Genentech, Crucell, Lycos and Plastic Logic. In most countries, universities can claim the...
8 KB (1,047 words) - 13:42, 3 March 2023
Corporation (1981–2006) Chiroscience (1991–1999) Covidien (2007–2015) Crucell (2000–2010) Cubist (1992–2015) Cutter (1897–1974) Cynapsus (1984–2016)...
34 KB (2,178 words) - 14:38, 14 November 2024
Galapagos Genomics NV was founded in 1999 as a joint venture between Crucell and Tibotec. The company later changed its name to Galapagos NV and completed...
6 KB (408 words) - 04:22, 18 January 2024
founded in 2012 by Ronald Brus, former CEO of the biotechnology company Crucell. In the beginning of its existence, myTomorrows has been characterized...
3 KB (213 words) - 13:14, 10 June 2022
Filovirus vaccine and Crucell/Janssen's AdVac technology based on adenoviral vectors, Bavarian Nordic joined efforts with Crucell Holland B.V., one of...
18 KB (1,177 words) - 09:53, 7 November 2024
Innovative medicine Actelion Alza Cilag Crucell Janssen Pharmaceuticals Janssen Biotech MorphoSys Ortho-McNeil Pharmaceutical Ortho-McNeil-Janssen Ortho...
7 KB (764 words) - 16:32, 18 September 2024
to get the chemistry right with joint CEOs". Reuters. 2 December 2019. "Crucell Announces Nomination of Ronald Brus as CEO". Klaas Knot wordt nieuwe president...
47 KB (4,565 words) - 08:33, 7 November 2024
mumps and rubella) at its Liverpool plant. Chiron in conjunction with Crucell (now part of Johnson & Johnson) developed a pentavalent vaccine called...
23 KB (2,299 words) - 20:32, 15 April 2024
Stolpe founded Galapagos NV in 1999 when he was recruited by the CEO of Crucell to set up a new genomics division for the company. He launched the division...
2 KB (207 words) - 09:13, 10 July 2024
The Scripps Research Institute and the Dutch biopharmaceutical company, Crucell. Immunology Friesen RH, Koudstaal W, Koldijk MH, Weverling GJ, Brakenhoff...
3 KB (278 words) - 00:59, 13 September 2024
2016.1165908. PMC 4994731. PMID 27105067. Kirschweger G (January 2003). "Crucell: biopharmaceuticals--as human as they get". Molecular Therapy. 7 (1): 5–6...
154 KB (13,894 words) - 23:13, 20 October 2024
Immunology. She moved to Crucell in 2010, which, at the time, was an independent biotechnology company. Two weeks later, Crucell was acquired by Janssen...
12 KB (1,134 words) - 20:34, 7 November 2024
a second vaccine as boost) – the first based on AdVac technology from Crucell Holland B.V. (which is part of Janssen), the second based on the MVA-BN...
67 KB (6,243 words) - 08:59, 30 September 2024
pursuing the vaccine as of 2009 and 2010 include Theraclone, VaxInnate, Crucell NV, Inovio Pharmaceuticals, Immune Targeting Systems (ITS) and iQur. In...
27 KB (2,791 words) - 11:50, 24 September 2024
had all earned their wealth through the sale of biotechnology company Crucell. Valerio had worked with Plasterk in the 1990s, and Löwenberg had introduced...
40 KB (3,645 words) - 05:24, 1 September 2024
Therapeutics, Cadent Therapeutics, Disarm Therapeutics, CoStim Pharmaceuticals, Crucell, deCODE genetics, Delinia, Exelixis, IFM Therapeutics Inc., Micromet, Momenta...
8 KB (690 words) - 18:57, 21 January 2024
Human embryonic kidney cells (HEK-293) Human embryonic retinal cells (Crucell's Per.C6) Human amniocyte cells (Glycotope and CEVEC)[citation needed] Cell-free...
25 KB (2,654 words) - 08:14, 28 October 2024
Manufacturers AstraZeneca Bharat Biotech BioMérieux BioNTech CSL Limited Crucell Eli Lilly Emergent BioSolutions GlaxoSmithKline Intercell Johnson & Johnson...
34 KB (2,323 words) - 08:13, 15 November 2024
Officer of Crucell and member of the management board. When Crucell was acquired by Johnson and Johnson Goudsmit became head of the Crucell Vaccine Institute...
6 KB (815 words) - 10:41, 15 June 2024
Johnson on its bid for all ordinary shares of the biopharmaceutical company Crucell N.V.. Cravath, Swaine & Moore served as US counsel to Johnson & Johnson...
6 KB (875 words) - 10:21, 22 August 2024